D
Dingdang Kuaiyao
Dingdang Kuaiyao is an online-to-offline drug purchasing and delivery platform
About Dingdang Kuaiyao
Dingdang Kuaiyao, which also operates under the name Dingdang Health, is a Chinese online-to-offline (O2O) platform for healthcare services, established in 2014 by founder and Chairman Yang Wenlong. Yang also serves as the CEO of Renhe Yaoye, a pharmaceutical developer, manufacturer, and retailer, a background that informed the creation of Dingdang Kuaiyao to address the unmet need for rapid medicine delivery.
The company's core business revolves around its mobile app and network of self-operated smart pharmacies, which provide 24/7 on-demand delivery of over-the-counter medicines and other healthcare products. A key feature of its service is the promise of delivery within 28 minutes in the cities it serves, a proposition that attracted early users, especially those needing medicine at night. The business operates on an asset-heavy model, directly managing its own pharmacies and logistics to ensure service speed and reliability. This self-supporting structure differentiates it from competitors that rely on third-party delivery platforms. Revenue is generated from the sale of pharmaceutical and healthcare products through its online platform and offline stores.
Beyond rapid delivery, Dingdang Kuaiyao has expanded its services to include online medical consultations, chronic disease management, and psychological counseling, leveraging AI and big data to enhance its offerings. The platform has experienced significant growth, fueled by substantial venture capital funding from investors such as SoftBank China, CMB International, TPG Capital Asia, and OrbiMed. This capital has supported its aggressive expansion plan across major Chinese cities. The company successfully listed on the Hong Kong Stock Exchange in September 2022.
Source: Dealroom company dataNews
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Jun 2021 | $220M | $880M | OrbiMed · Summer Capital · Valliance Capital · TPG | — |
| SERIES COther financing | Oct 2020 | $138M | $550M | Haier Biomedical · CICC · SB China Capital · Taikang Life Insurance | — |
Growth signals
Latest recorded traffic for Dingdang Kuaiyao is 0 monthly website visits, down 100% over the last three months. Dingdang Kuaiyao's team grew 0% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Dingdang Kuaiyao in the Dongcheng District ecosystem
The Dingdang Kuaiyao office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
- TCTongdaoo Capital
SB China Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Dingdang Kuaiyao on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Dingdang Kuaiyao’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.



















